Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siemuron vs vitamin E cream for prevention and treatment of radiation dermatitis after head and neck tumor and breast cancer radiotherapy
ChiCTR2100050910Phase 4Recruiting
- Sponsor
- Xijing Hospital
- Start
- Sep 2021
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of siemuron in radiodermatitis (2 arms), sponsored by Xijing Hospital. Primary endpoint: Incidence of grade II or higher radiation dermatitis. Started Sep 2021; status: recruiting.
02
Drugs
siemuron
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on ChiCTR2100050910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050910.